p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epithelium
Senescence has been implicated as an important mechanism of tumour suppression in a number of human malignancies, including colorectal cancer (CRC). However, we still have a relatively poor understanding of how the underlying mutations that occur in cancer cause senescence and its relevance in vivo...
Gespeichert in:
Veröffentlicht in: | EMBO molecular medicine 2010-11, Vol.2 (11), p.472-486 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Senescence has been implicated as an important mechanism of tumour suppression in a number of human malignancies, including colorectal cancer (CRC). However, we still have a relatively poor understanding of how the underlying mutations that occur in cancer cause senescence and its relevance
in vivo
. The
Apc
gene is mutated in approximately 80% of CRC as the initiating event, but rarely elsewhere. In this study we have examined the capacity of
Apc
loss to induce senescence in the intestinal epithelium compared to the renal epithelium. Within the renal epithelium, loss of
Apc
function led to an induction of senescence, however, bypassing senescence through combined
Apc
and
p21
or
Ink4A
gene deletion rapidly initiated renal carcinoma. Within the intestinal epithelium, loss of
Apc
did not induce senescence. Moreover, combined
Apc
and
p21
or
Ink4A
loss had no impact upon tumourigenesis. Taken together, these results show that
Apc
loss
in vivo
invokes a senescence program in a context‐dependent fashion, and implies senescence may play a key barrier to tumourigenesis in the kidney. However, in CRC, escape from senescence is likely to only be a barrier in cancers initiated by other mutations. |
---|---|
ISSN: | 1757-4676 1757-4684 |
DOI: | 10.1002/emmm.201000101 |